Literature DB >> 16902939

FlexNovo: structure-based searching in large fragment spaces.

Jörg Degen1, Matthias Rarey.   

Abstract

We present a new molecular design program, FlexNovo, for structure-based searching within large fragment spaces following a sequential growth strategy. The fragment spaces consist of several thousands of chemical fragments and a corresponding set of rules that specify how the fragments can be connected. FlexNovo is based on the FlexX molecular docking software and makes use of its incremental construction algorithm and the underlying chemical models. Interaction energies are calculated by using standard scoring functions. Several placement geometry, physicochemical property (drug-likeness), and diversity filter criteria are directly integrated into the "build-up" process. FlexNovo has been used to design potential inhibitors for four targets of pharmaceutical interest (dihydrofolate reductase, cyclin-dependant kinase 2, cyclooxygenase-2, and the estrogen receptor). We have carried out calculations using different diversity parameters for each of these targets and generated solution sets containing up to 50 molecules. The compounds obtained show that FlexNovo is able to generate a diverse set of reasonable molecules with drug-like properties. The results, including an automated similarity analysis with the Feature Tree program, indicate that FlexNovo often reproduces structural motifs as well as the corresponding binding modes seen in known active structures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16902939     DOI: 10.1002/cmdc.200500102

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  8 in total

1.  Second-generation de novo design: a view from a medicinal chemist perspective.

Authors:  Andrea Zaliani; Krisztina Boda; Thomas Seidel; Achim Herwig; Christof H Schwab; Johann Gasteiger; Holger Claussen; Christian Lemmen; Jörg Degen; Juri Pärn; Matthias Rarey
Journal:  J Comput Aided Mol Des       Date:  2009-06-27       Impact factor: 3.686

2.  De novo design by pharmacophore-based searches in fragment spaces.

Authors:  Tobias Lippert; Tanja Schulz-Gasch; Olivier Roche; Wolfgang Guba; Matthias Rarey
Journal:  J Comput Aided Mol Des       Date:  2011-09-16       Impact factor: 3.686

3.  Combinatorial library-based design with Basis Products.

Authors:  Joe Zhongxiang Zhou; Shenghua Shi; Jim Na; Zhengwei Peng; Tom Thacher
Journal:  J Comput Aided Mol Des       Date:  2009-07-11       Impact factor: 3.686

Review 4.  De novo molecular drug design benchmarking.

Authors:  Lauren L Grant; Clarissa S Sit
Journal:  RSC Med Chem       Date:  2021-06-03

5.  Structure-based discovery of A2A adenosine receptor ligands.

Authors:  Jens Carlsson; Lena Yoo; Zhan-Guo Gao; John J Irwin; Brian K Shoichet; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

6.  Novel inhibitors of anthrax edema factor.

Authors:  Deliang Chen; Milind Misra; Laurie Sower; Johnny W Peterson; Glen E Kellogg; Catherine H Schein
Journal:  Bioorg Med Chem       Date:  2008-06-28       Impact factor: 3.641

7.  Disruption of intrinsic motions as a mechanism for enzyme inhibition.

Authors:  Rebecca J Swett; G Andrés Cisneros; Andrew L Feig
Journal:  Biophys J       Date:  2013-07-16       Impact factor: 4.033

8.  Exploring fragment spaces under multiple physicochemical constraints.

Authors:  Juri Pärn; Jörg Degen; Matthias Rarey
Journal:  J Comput Aided Mol Des       Date:  2007-06-28       Impact factor: 4.179

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.